Clinical trials - Press Releases

Date	Title	Company
29-Sep-2021	New data reinforce efficacy and convenience of Novartis Cosentyx® (secukinumab) 300 mg autoinjector in adults with psoriasis	Novartis
29-Sep-2021	Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate	Sanofi
29-Sep-2021	Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis that Confirm Ability to Harness the Small Intestinal Axis, SINTAX™, to Treat Systemic Inflammatory Disease	Evelo Biosciences
29-Sep-2021	ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular Dystrophy	ReveraGen
28-Sep-2021	Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate	Sanofi
23-Sep-2021	CyPep-1 Shows Preliminary Safety, Tolerability and Early Signs of Efficacy in Part 1 of its Ph I/IIa CICILIA Trial Which Now Moves to Expansion Phase	Cytovation
22-Sep-2021	Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.	Johnson & Johnson
22-Sep-2021	DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder	DemeRx
22-Sep-2021	HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA® in Combination with TUOYI® in the Treatment of Advanced Neuroendocrine Carcinoma in China	HUTCHMED
22-Sep-2021	HUTCHMED Initiates a Japan Bridging Study to Support Surufatinib Registration for Advanced Neuroendocrine Tumors	HUTCHMED
20-Sep-2021	Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with Erdafitinib in Combination with Cetrelimab, a PD-1 Inhibitor	The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2021	Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference	SMi Group
20-Sep-2021	Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation	Novartis
16-Sep-2021	Egnyte Announces New Solution for Clinical Trial Operations	Egnyte
16-Sep-2021	Transgene presents data from Phase I clinical trial confirming the potential of the oncolytic virus TG6002	Transgene
16-Sep-2021	Nouscom announces initial results from Phase 1 trial for NOUS-209, an 'off-the-shelf' neoantigen cancer vaccine, in MSI-H solid tumors	Nouscom
13-Sep-2021	Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial	Cytel
10-Sep-2021	atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression	atai Life Sciences and Introspect Digital Therapeutics
09-Sep-2021	Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus	Sanofi
09-Sep-2021	PT027 Phase III trials met primary endpoints	AstraZeneca